New publication: Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study

2019-03-18T12:44:24+00:00 March 18th, 2019|Categories: Endocrine, nutritional and metabolic diseases, Health Economics|

Our paper "Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study" was recently published in The Journal of Medical Internet Research. The study assessed the effects associated with the electronic health (eHealth) intervention among obese diabetes patients in a real-life municipal setting. A real-life eHealth lifestyle coaching intervention was implemented in [...]

Prof. Anders Green at the 5th International Conference on Interdisciplinary Management of Diabetes Mellitus and its Complications

2019-03-18T11:32:54+00:00 March 18th, 2019|Categories: Cancer, Endocrine, nutritional and metabolic diseases, Nordic Health Registers|

Is diabetes per se a risk factor for developing cancer? Or is diabetes a marker of an underlying (pre-clinical) cancer process? Professor Anders Green from ApHER gave an invited presentation exploring these questions at the 5th International Conference on Interdisciplinary Management of Diabetes which took place the 7th to 9th of March in Bucharest, Romania. Read [...]

It is a good investment to prevent the development of lifestyle diseases such as diabetes

2018-09-28T13:44:19+00:00 March 31st, 2018|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.

Register studies of diabetes treatment arouse method discussions

2018-08-03T15:25:19+00:00 September 25th, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers|

Randomized studies of SLGT-2 inhibitors and GLP-1 receptor agonists are now followed-up by register studies. And scientists are eagerly presenting real life data these years. This makes professor Anders Green to point out that scientists need to remember openness towards each others' methodological schools. Read the article from Medicinsk Tidsskrift here.

Annual meeting of the Scandinavian Society for the study of diabetes

2018-08-03T15:26:33+00:00 May 21st, 2017|Categories: Endocrine, nutritional and metabolic diseases, Nordic Health Registers, Pharmacoepidemiology|

Professor Anders Green gave an invited presentation on the epidemiological results from the Diabetes Impact Study in connection with the Annual Meeting of the Scandinavian Society for the Study of Diabetes, held the 19th-21st of May in Nyborg (Denmark).

UTURN – a life without pills

2018-08-20T15:11:44+00:00 January 14th, 2017|Categories: Endocrine, nutritional and metabolic diseases, Health Economics|

The program UTURN - a life without pills on DR1 (Danish national television), is a part of a research project at Rigshospitalet in Copenhagen, which examines wheter an intensive life style intervention in diabetes patients can reduce patients' need for pharmaceutical treatment for diabetes. Camilla Sorts from ApEHR explains in this program the socio-economical cost of [...]

Staying in good health adds economic value to our societies

2018-08-20T15:05:22+00:00 December 14th, 2016|Categories: Cancer, Diseases of the nervous system, Endocrine, nutritional and metabolic diseases, Health Economics|

In collaboration, Dr. Hans Martens and APEHR have completed a blog discussing the challenge of chronic disease for Europe's health systems. Link to the blog.

Status of the diabetes situation in Denmark: Social inequality in diabetes morbidity

2018-08-20T15:50:37+00:00 October 2nd, 2016|Categories: Cancer, Endocrine, nutritional and metabolic diseases|

PhD and M.Sc. Camilla Sortsø gives a status on the diabetes morbidity in Denmark and how social inequality plays an important role in the Danish program "En syg forskel" (red. An ill difference). The program is about how social conditions is important in relation to children with chronic diseases as diabetes and cancer.

Decomposing inequality in diabetes patients’ morbidity patterns, survival and health care usage in Denmark

2018-08-20T16:52:36+00:00 May 12th, 2016|Categories: Endocrine, nutritional and metabolic diseases, Health Economics|

In collaboration, APEHR and the Centre of Health Economics Research (COHERE) have completed a discussion paper to quantify inequality in diabetes morbidity patterns, survival and health care service usage and understand determinants of these inequalities in relation to socio-demographic and clinical morbidity factors. Link to publication.